"We did not meet our financial goals in 2024, and that's reflected in our corporate bonus," a company representative told ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.

Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk factor" sections of filings, contrasting with their publicly positive ...

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

Trump, along with billionaire Elon Musk, is moving rapidly to shrink the federal workforce, raise barriers to trade and immigration, and expand the White House’s control of government agencies.